Calpain-mediated integrin deregulation as a novel mode of action for the anticancer gallium compound KP46.
Jungwirth U, Gojo J, Tuder T, Walko G, Holcmann M, Schöfl T, Nowikovsky K, Wilfinger N, Schoonhoven S, Kowol CR, Lemmens-Gruber R, Heffeter P, Keppler BK, Berger W.
Jungwirth U, et al.
Mol Cancer Ther. 2014 Oct;13(10):2436-49. doi: 10.1158/1535-7163.MCT-14-0087. Epub 2014 Jul 31.
Mol Cancer Ther. 2014.
PMID: 25082959